Strategic Research Analysis ­ Positioning to Benefit on Abbott, Rite Aid, Kroger, Celgene, Twitter, and NIKE ­ Effects of Key Drivers of Growth and Emerging Market Trends

NEW YORK, Oct. 10, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Abbott Laboratories ABT, Rite Aid Corporation RAD, The Kroger Co. KR, Celgene Corporation CELG, Twitter, Inc. TWTR, and NIKE, Inc. NKE including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

ABT DOWNLOAD: http://Fundamental-Markets.com/register/?so=ABT

RAD DOWNLOAD: http://Fundamental-Markets.com/register/?so=RAD

KR DOWNLOAD: http://Fundamental-Markets.com/register/?so=KR

CELG DOWNLOAD: http://Fundamental-Markets.com/register/?so=CELG

TWTR DOWNLOAD: http://Fundamental-Markets.com/register/?so=TWTR

NKE DOWNLOAD: http://Fundamental-Markets.com/register/?so=NKE

 (You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine  Abbott Laboratories ABT, Rite Aid Corporation RAD, The Kroger Co. KR, Celgene Corporation CELG, Twitter, Inc. TWTR, and NIKE, Inc. NKE on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. All information in this release was accessed October 9, 2017. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All amounts in millions (except per share amounts).

-----------------------------------------

ABBOTT LABORATORIES (ABT) REPORT OVERVIEW

Certified Factual by Registered Analyst

Abbott Laboratories' Recent Financial Performance

For the three months ended June 30, 2017 vs June 30, 2016, Abbott Laboratories reported revenue of $6,637 vs $5,333 (up 24.5%), diluted earnings per share $0.16 vs $0.41 (down 61.0%), and dividends per share $0.265 vs $0.26 (up 1.9%). During fiscal year 2016 vs fiscal 2015, Abbott Laboratories reported revenue of $20,853 vs $20,405 (up 2.2%), diluted earnings per share $0.94 vs $2.92 (down 67.8%), and dividends per share $1.045 vs $0.98 (up 6.6%). Abbott Laboratories is expected to report earnings on 10/18/2017. The report will be for the fiscal Quarter ending September 2017. According to Zacks Investment Research, based on 11 analysts' forecasts, the consensus EPS forecast for the quarter is $0.65. The reported EPS for the same quarter last year was $0.59.

To read the full Abbott Laboratories (ABT) report, download it here: http://Fundamental-Markets.com/register/?so=ABT

-----------------------------------------

RITE AID CORPORATION (RAD) REPORT OVERVIEW

Certified Factual by Registered Analyst

Rite Aid's Recent Financial Performance

For the thirteen week period ended June 3, 2017 vs May 28, 2016, Rite Aid reported revenue of $7,781 vs $8,184 (down 4.9%) and diluted earnings per share -$0.07 vs $0.00. During fiscal year 2016 vs fiscal 2015, Rite Aid reported revenue of $30,736 vs $26,528 (up 15.9%) and diluted earnings per share $0.16 vs $2.08 (down 92.3%).

To read the full Rite Aid Corporation (RAD) report, download it here: http://Fundamental-Markets.com/register/?so=RAD

-----------------------------------------

THE KROGER CO. (KR) REPORT OVERVIEW

Certified Factual by Registered Analyst

Kroger's Recent Financial Performance

For the three months ended August 12, 2017 vs August 13, 2016, Kroger reported revenue of $27,597 vs $26,565 (up 3.9%), diluted earnings per share $0.39 vs $0.40 (down 2.5%), and dividends per share $0.125 vs $0.12 (up 4.2%). During fiscal year 2016 vs fiscal 2015, Kroger reported revenue of $115,337 vs $109,830 (up 5.0%), diluted earnings per share $2.05 vs $2.06 (down 0.5%), and dividends per share $0.465 vs $0.408 (up 14.0%).

To read the full The Kroger Co. (KR) report, download it here: http://Fundamental-Markets.com/register/?so=KR

-----------------------------------------

CELGENE CORPORATION (CELG) REPORT OVERVIEW

Certified Factual by Registered Analyst

Celgene's Recent Financial Performance

For the three months ended June 30, 2017 vs June 30, 2016, Celgene reported net earnings of $3,268 vs $2,754 (up 18.7%) and diluted earnings per share $1.31 vs $0.75 (up 74.7%). During fiscal year 2016 vs fiscal 2015, Celgene reported net earnings of $11,229.2 vs $9,256.0 (up 21.3%) and diluted earnings per share $2.49 vs $1.94 (up 28.4%). Celgene is expected to report earnings on 10/26/2017. The report will be for the fiscal Quarter ending September 2017. According to Zacks Investment Research, based on 8 analysts' forecasts, the consensus EPS forecast for the quarter is $1.72. The reported EPS for the same quarter last year was $1.39.

To read the full Celgene Corporation (CELG) report, download it here: http://Fundamental-Markets.com/register/?so=CELG

-----------------------------------------

TWITTER, INC. (TWTR) REPORT OVERVIEW

Certified Factual by Registered Analyst

Twitter's Recent Financial Performance

For the three months ended June 30, 2017 vs June 30, 2016, Twitter reported revenue of $573.86 vs $601.96 (down 4.7%) and diluted earnings per share -$0.16 vs -$0.15. During fiscal year 2016 vs fiscal 2015, Twitter reported revenue of $2,529.62 vs $2,218.03 (up 14.1%) and diluted earnings per share -$0.65- vs -$0.79. Twitter is expected to report earnings on 10/26/2017. The report will be for the fiscal Quarter ending September 2017. According to Zacks Investment Research, based on 8 analysts' forecasts, the consensus EPS forecast for the quarter is -$0.03. The reported EPS for the same quarter last year was -$0.10.

To read the full Twitter, Inc. (TWTR) report, download it here: http://Fundamental-Markets.com/register/?so=TWTR

-----------------------------------------

NIKE, INC. (NKE) REPORT OVERVIEW

Certified Factual by Registered Analyst

Nike's Recent Financial Performance

For the three months ended February 28, 2017 vs February 29, 2016, Nike reported revenue of $8,432 vs $8,032 (up 5.0%), diluted earnings per share $0.68 vs $0.55 (up 23.6%), and dividends per share $0.18 vs $0.16 (up 12.5%). During fiscal year 2017 vs fiscal 2016, Nike reported revenue of $34,350 vs $32,376 (up 6.1%), diluted earnings per share $2.51 vs $2.16 (up 16.2%), and dividends per share $0.70 vs $0.62 (up 12.9%).

To read the full NIKE, Inc. (NKE) report, download it here: http://Fundamental-Markets.com/register/?so=NKE

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade—and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as  Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by GlobeNewswire staff, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@fundamental-markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: andrew.duffie@fundamental-markets.com

© 2017 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@fundamental-markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.